On November 9, speaking at a board session of Tatneftekhiminvest-holding held by Tatarstan President Rustam Minnikhanov, Director of the Nanolek Russian pharmaceutical company Vladimir Khristenko said that Nanolek, which built a biomedical complex in Kirov region, intends to establish cooperation with the Tatarstan pharmaceuticals company Tatkhimpharmpreparaty for the production of import-substituting innovative medicines.
Nanolek, set up in 2011 in association with RUSNANO company, focuses on prevention and treatment of socially significant diseases. Russia's first pentavaccine, a joint project with the French company Sanofi Pasteur, is its key area. In October 2016 Nanolek started production of vaccines.
Nanolek is working with Tatkhimpharmpreparaty on localization of its production facilities in the republic.
Summing up the meeting, Minnikhanov proposed Nanolek management using scientific potential of Tatarstan.